Single-agent irinotecan as second-line treatment for advanced gastric cancer

Kanat O., Evrensel T., Manavoglu O., Demiray M., Kurt E., Gonullu G., ...Daha Fazla

TUMORI JOURNAL, cilt.89, sa.4, ss.405-407, 2003 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 89 Sayı: 4
  • Basım Tarihi: 2003
  • Doi Numarası: 10.1177/030089160308900411
  • Dergi Adı: TUMORI JOURNAL
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.405-407
  • Anahtar Kelimeler: gastric cancer, irinotecan, second-line chemotherapy, SUPPORTIVE CARE, PHASE-II, METHOTREXATE, CARBOPLATIN, PACLITAXEL, CISPLATIN
  • Bursa Uludağ Üniversitesi Adresli: Evet

Özet

Aim: To investigate the activity and toxicity of irinotecan (CPT-11) as a single agent in patients with advanced gastric cancer after failure of previous 5-fluorouracil-based combination chemotherapy.